Dr. Chin, an oncology specialist, most recently served as senior vice president and head of clinical development at 2Seventy Bio, a biotechnology company, according to a March 1 news release from Marengo.
In his new role, Dr. Chin will manage the development of the company’s clinical portfolio, the release said.
